Export 153 results:
Filters: Author is Dupré, Nicolas  [Clear All Filters]
Rudakou U, Bencheikh BOuled Amar, Ruskey JA, Krohn L, Laurent SB, Spiegelman D, Liong C, Fahn S, Waters C, Monchi O, Fon EA, Dauvilliers Y, Alcalay RN, Dupré N, Gan-Or, iv Z. Common and rare GCH1 variants are associated with Parkinson's disease. Neurobiol Aging. 2019;73:231.e1-231.e6.
Giguère-Rancourt A, Plourde M, Doiron M, Langlois M, Dupré N, Simard M. Goal management training ® home-based approach for mild cognitive impairment in Parkinson's disease: a multiple baseline case report. Neurocase. 2019;:1-11.
Lamontagne-Proulx J, St-Amour I, Labib R, Pilon J, Denis HL, Cloutier N, Roux-Dalvai F, Vincent AT, Mason SL, Williams-Gray C, Duchez A-C, Droit A, Lacroix S, Dupré N, Langlois M, Chouinard S, Panisset M, Barker RA, Boilard E, Cicchetti F. Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease. Neurobiol Dis. 2019;124:163-175.
Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, Waters C, Kuo S-H, Chung WK, Ford B, Marder KS, Kang UJung, Hassin-Baer S, Greenbaum L, Trempe J-F, Wolf P, Oliva P, Zhang XKate, Clark LN, Langlois M, Dion PA, Fon EA, Dupré N, Rouleau GA, Gan-Or, iv Z. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. Mov Disord. 2019;34(4):526-535.
Schmouth J-F, Houle G, Ambalavanan A, Leblond CS, Spiegelman D, Laurent SB, Bourassa CV, Panisset M, Chouinard S, Dupré N, Vilariño-Güell C, Rajput A, Dion PA, Rouleau GA. Absence of Mutation Enrichment for Genes Phylogenetically Conserved in the Olivocerebellar Motor Circuitry in a Cohort of Canadian Essential Tremor Cases. Mol Neurobiol. 2018;.
Ross JP, Mohtashami S, Leveille E, Johnson AM, Xiong L, Dion PA, Fon E, Dauvilliers Y, Dupré N, Rouleau GA, Gan-Or, iv Z. Association study of essential tremor genetic loci in Parkinson's disease. Neurobiol Aging. 2018;66:178.e13-178.e15.
Picher-Martel V, Dupré N. Current and Promising Therapies in Autosomal Recessive Ataxias. CNS Neurol Disord Drug Targets. 2018;17(3):161-171.
Roy M-A, Doiron M, Talon-Croteau J, Dupré N, Simard M. Effects of Antiparkinson Medication on Cognition in Parkinson's Disease: A Systematic Review. Can J Neurol Sci. 2018;45(4):375-404.
Li J, Ruskey JA, Arnulf I, Dauvilliers Y, Hu MTM, Högl B, Leblond CS, Zhou S, Ambalavanan A, Ross JP, Bourassa CV, Spiegelman D, Laurent SB, Stefani A, Monaca CCharley, De Cock VCochen, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Labbe C, Ferman TJ, Dion PA, Fan D, Desautels A, Gagnon J-F, Dupré N, Fon EA, Montplaisir JY, Boeve BF, Postuma RB, Rouleau GA, Ross OA, Gan-Or, iv Z. Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder. Mov Disord. 2018;33(6):1016-1020.
Zhou S, Gan-Or, iv Z, Ambalavanan A, Lai D, Xie P, Bourassa CV, Strong S, Ross JP, Dionne-Laporte A, Spiegelman D, Dupré N, Foroud TM, Xiong L, Dion PA, Rouleau GA. Genome-wide association analysis identifies new candidate risk loci for familial intracranial aneurysm in the French-Canadian population. Sci Rep. 2018;8(1):4356.
Paré B, Lehmann M, Beaudin M, Nordström U, Saikali S, Julien J-P, Gilthorpe JD, Marklund SL, Cashman NR, Andersen PM, Forsberg K, Dupré N, Gould P, Brännström T, Gros-Louis F. Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci Rep. 2018;8(1):14223.
Gauquelin L, Tétreault M, Thiffault I, Farrow E, Miller N, Yoo B, Bareke E, Yoon G, Suchowersky O, Dupré N, Tarnopolsky M, Brais B, Wolf NI, Majewski J, Rouleau GA, Gan-Or, iv Z, Bernard G. POLR3A variants in hereditary spastic paraplegia and ataxia. Brain. 2018;141(1):e1.
Bencheikh BOuled Amar, Leveille E, Ruskey JA, Spiegelman D, Liong C, Fon EA, Rouleau GA, Dauvilliers Y, Dupré N, Alcalay RN, Gan-Or, iv Z. Sequencing of the GBA coactivator, Saposin C, in Parkinson disease. Neurobiol Aging. 2018;.
Bereznyakova O, Dupré N. Spastic ataxias. Handb Clin Neurol. 2018;155:191-203.
Mohtashami S, He Q, Ruskey JA, Zhou S, Dion PA, Allen RP, Earley CJ, Fon EA, Xiong L, Dupré N, Dauvilliers Y, Rouleau GA, Gan-Or, iv Z. TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson's Disease with Opposite Effects. J Mol Neurosci. 2018;64(3):341-345.
Chrestian N, Dupré N, Gan-Or, iv Z, Szuto A, Chen S, Venkitachalam A, Brisson J-D, Warman-Chardon J, Ahmed S, Ashtiani S, MacDonald H, Mohsin N, Mourabit-Amari K, Provencher P, Boycott KM, Stavropoulos DJ, Dion PA, Ray PN, Suchowersky O, Rouleau GA, Yoon G. Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurol Genet. 2017;3(1):e122.
Gan-Or, iv Z, Montplaisir JY, Ross JP, Poirier J, Warby SC, Arnulf I, Strong S, Dauvilliers Y, Leblond CS, Hu MTM, Högl B, Stefani A, Monaca CCharley, De Cock VCochen, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Barber TR, Evetts SG, Rolinski M, Dion PA, Desautels A, Gagnon J-F, Dupré N, Postuma RB, Rouleau GA. The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder. Neurobiol Aging. 2017;49:218.e13-218.e15.
Doiron M, Langlois M, Dupré N, Simard M. The influence of vascular risk factors on cognitive function in early Parkinson's disease. Int J Geriatr Psychiatry. 2017;.
Gan-Or, iv Z, Yoon G, Suchowersky O, Dupré N, Rouleau GA. KCNA2 mutations are rare in hereditary spastic paraplegia. Ann Neurol. 2017;81(2):325-326.
Ross JP, Dupré N, Dauvilliers Y, Strong S, Dionne-Laporte A, Dion PA, Rouleau GA, Gan-Or, iv Z. RIC3 variants are not associated with Parkinson's disease in French-Canadians and French. Neurobiol Aging. 2017;53:194.e9-194.e11.
Doiron M, Dupré N, Langlois M, Provencher P, Simard M. Smoking history is associated to cognitive impairment in Parkinson's disease. Aging Ment Health. 2017;21(3):322-326.